Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niti Sureka

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Acta Cytologica|February 25, 2025
Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda SystemNiti Sureka, Charanjeet Ahluwalia, Sana Ahuja, et al.
Pathology, Research and Practice|March 11, 2025
Exploring immune checkpoint inhibitors: Focus on PD-1/PD-L1 axis and beyondDurre Aden, Samreen Zaheer, Niti Sureka, et al.
Frontiers in Oncology|June 22, 2026
Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancerNazia Nazam, Shaikh Sadiya, Saba Khan, et al.
Frontiers in Oncology|April 16, 2026
Hypoxic microenvironment in cancer: role in metabolic reprogrammingNiti Sureka, Rashi Maheshwari, Amit Agravat, et al.
Cell Biology International|September 29, 2025
Matter of Fat: Cancer-Associated Adipocytes as Mediators of Tumor Progression and Immune EvasionNiti Sureka, Shikhar Chohan, Samreen Zaheer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Acta Cytologica|February 25, 2025
Assessment of Thyroid Fine-Needle Aspirates Using 2023 Bethesda SystemNiti Sureka, Charanjeet Ahluwalia, Sana Ahuja, et al.
Pathology, Research and Practice|March 11, 2025
Exploring immune checkpoint inhibitors: Focus on PD-1/PD-L1 axis and beyondDurre Aden, Samreen Zaheer, Niti Sureka, et al.
Frontiers in Oncology|June 22, 2026
Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancerNazia Nazam, Shaikh Sadiya, Saba Khan, et al.
Frontiers in Oncology|April 16, 2026
Hypoxic microenvironment in cancer: role in metabolic reprogrammingNiti Sureka, Rashi Maheshwari, Amit Agravat, et al.
Cell Biology International|September 29, 2025
Matter of Fat: Cancer-Associated Adipocytes as Mediators of Tumor Progression and Immune EvasionNiti Sureka, Shikhar Chohan, Samreen Zaheer, et al.
Pageof 2